An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment.
- DOI
- 10.1016/j.omtn.2025.102802
- Published
- 2026 Mar 12
- Container
- Molecular therapy. Nucleic acids
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.omtn.2025.102802,
title = {An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment.},
author = {Maeda K and Hirunagi T and Sahashi K and Kamiya Y and Iida M and Sakakibara K and Onodera K and Ohyama M and Okada Y and Okano H and Asanuma H and Katsuno M},
year = {2026},
journal = {Molecular therapy. Nucleic acids},
doi = {10.1016/j.omtn.2025.102802},
url = {https://doi.org/10.1016/j.omtn.2025.102802}
}RIS
TY - JOUR TI - An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment. AU - Maeda K AU - Hirunagi T AU - Sahashi K AU - Kamiya Y AU - Iida M AU - Sakakibara K AU - Onodera K AU - Ohyama M AU - Okada Y AU - Okano H AU - Asanuma H AU - Katsuno M PY - 2026 JO - Molecular therapy. Nucleic acids DO - 10.1016/j.omtn.2025.102802 UR - https://doi.org/10.1016/j.omtn.2025.102802 ER -
APA
K, M., T, H., K, S., Y, K., M, I., K, S., K, O., M, O., Y, O., H, O., H, A., & M, K. (2026). An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment.. Molecular therapy. Nucleic acids. https://doi.org/10.1016/j.omtn.2025.102802
Source records
- pubmed · retrieved 2026-09-27T15:56:47.458Z